[Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method]
- PMID: 19795615
[Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method]
Abstract
The performance of the fully automated BACTEC MGIT 960 (Becton Dickinson, Cockeysville, Md.) system for susceptibility testing of Mycobacterium tuberculosis to critical concentrations of 4 major antituberculosis drugs [streptomycin (STR), isoniazid (INH), rifampin (RIF) and ethambutol (EMB)] was evaluated with 100 clinical isolates and compared to that of the radiometric BACTEC 460 TB (Becton Dickinson, Sparks, Md.) system. The results of BACTEC 960 MGIT, which are not compatible with BACTEC 460 TB, were re-evaluated according to the results obtained. The discordance was 2.25% at the critical concentrations of both systems. After the reproducibility testing, the discordance between 2 systems reduced to 1.25% and the concordance increased to 98.75%. In our study, no very major error was observed; major error was detected as 2.25% (STR 2, INH 4, RIF 2 and EMB 1) in the 1st trial, and 1.25% (INH 3, RIF 2) in the 2nd trial. When BACTEC 460 TB has been compared with BACTEC 960 MGIT, the overall specificity was 100% in all tests, the sensitivity was 95.6-98.9% in the initial testing, however, the sensitivity changed to 96.7-100% after the reproducibility testing. It was concluded that there was no statistically significant disconcordance between the two test systems. Thus BACTEC MGIT 960 might be an alternative to BACTEC 460 TB for susceptibility testing of antituberculosis agents.
Similar articles
-
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.J Clin Microbiol. 2007 Jun;45(6):1766-70. doi: 10.1128/JCM.02162-06. Epub 2007 Apr 18. J Clin Microbiol. 2007. PMID: 17442793 Free PMC article.
-
Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.Ann Clin Lab Sci. 2002 Spring;32(2):142-7. Ann Clin Lab Sci. 2002. PMID: 12017195
-
Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.Tuberculosis (Edinb). 2007 Mar;87(2):102-8. doi: 10.1016/j.tube.2006.05.002. Epub 2006 Oct 10. Tuberculosis (Edinb). 2007. PMID: 17035089
-
Isoniazid resistance in Rifampicin sensitive pulmonary tuberculosis in children and adolescents.Indian J Tuberc. 2024;71 Suppl 1:S145-S148. doi: 10.1016/j.ijtb.2024.05.002. Epub 2024 May 9. Indian J Tuberc. 2024. PMID: 39067947 Review.
-
Diagnostic test of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis.J Evid Based Med. 2011 Feb;4(1):15-21. doi: 10.1111/j.1756-5391.2011.01117.x. J Evid Based Med. 2011. PMID: 21342484 Review.
Cited by
-
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.BMC Infect Dis. 2019 Feb 7;19(1):129. doi: 10.1186/s12879-019-3757-1. BMC Infect Dis. 2019. PMID: 30732572 Free PMC article.